AFR07, NCT00763763: Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive |
|
|
| Completed | 2 | 55 | Europe | Imatinib mesylate, Interferon, Pegasys, Interferon, Pegasys, Vincristine, Dexamethasone | Assistance Publique - Hôpitaux de Paris | Leukemia, Lymphocytic, Acute, Philadelphia Chromosome, Blast Crisis, Leukemia, Myeloid, Chronic | 10/07 | 01/10 | | |
NCT01392170: Pegasys in Patients With Chronic Myeloid Leukemia (CML) |
|
|
| Terminated | 2 | 2 | US | PEG-IFNá-2a, Pegasys, Peginterferon Alpha-2a | M.D. Anderson Cancer Center | Leukemia | 03/14 | 03/14 | | |
| Completed | 2 | 135 | US, Europe | PEGASYS, Pegylated Interferon Alfa-2a, Aspirin, acetylsalicylic acid | Ronald Hoffman, Myeloproliferative Disorders-Research Consortium, National Cancer Institute (NCI), Roche Pharma AG | High Risk Polycythemia Vera, High Risk Essential Thrombocythemia | 12/16 | 12/16 | | |
